Skip to Main Content

Author Details

Ann W McMahon
Center for Drug Evaluation and Research
2005
35
15
PMIDPaper TitleJournal TitlePublished Year
35968821Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-Response.J Clin Pharmacol2023
34090699Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.Vaccine2021
34251405Summary of Literature on Pediatric Real-world Evidence and Effectiveness.JAMA Pediatr2021
34185899Drug Safety in Labeling for Pediatric Drug Development and Dose Selection in Submissions to the US Food and Drug Administration.J Clin Pharmacol2021
32112359Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review.Drugs Real World Outcomes2020
31937606Big Data in the Assessment of Pediatric Medication Safety.Pediatrics2020
32037154Acute Kidney Injury During Treatment with Intravenous Acyclovir for Suspected or Confirmed Neonatal Herpes Simplex Virus Infection.J Pediatr2020
32813442Methodologic approaches in studies using real-world data to measure pediatric safety and effectiveness of vaccines administered to pregnant women: a scoping review protocol.JBI Evid Synth2020
30452504Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration.JAMA Pediatr2019
30484072Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.Paediatr Drugs2019
29874532Assessing Drug Safety in Children - The Role of Real-World Data.N Engl J Med2018
28028203Development of a Pediatric Adverse Events Terminology.Pediatrics2017
28924994Workshop on evaluation of pediatric long-term neurocognitive development and medical products.Pharmacoepidemiol Drug Saf2017
27910218Octreotide use and safety in infants with hyperinsulinism.Pharmacoepidemiol Drug Saf2017
26687996Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success.Pharmacoepidemiol Drug Saf2016
27774353Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug Development.Ther Innov Regul Sci2016
25968047Safety of octreotide in hospitalized infants.Early Hum Dev2015
26098297Pediatric post-marketing safety systems in North America: assessment of the current status.Pharmacoepidemiol Drug Saf2015
25287454Adherence to guidelines for glucose assessment in starting second-generation antipsychotics.Pediatrics2014
22711728Trends of outpatient prescription drug utilization in US children, 2002-2010.Pediatrics2012
23067905Pediatric cardiovascular safety: challenges in drug and device development and clinical application.Am Heart J2012
21042229Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting System.Pediatr Infect Dis J2011
22025595Age and risks of FDA-approved long-acting β⿿-adrenergic receptor agonists.Pediatrics2011
20661880Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.Pharmacoepidemiol Drug Saf2010
20506368Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration.Arthritis Rheum2010
19450636Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.Vaccine2009
18093701Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.Vaccine2008
19052120Outbreak of adverse reactions associated with contaminated heparin.N Engl J Med2008
17240001Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.Vaccine2007
17540484Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.Vaccine2007
17154344Comparison of military and civilian reporting rates for smallpox vaccine adverse events.Pharmacoepidemiol Drug Saf2007
16517033Passive surveillance for generalized vaccinia in the United States using the Vaccine Adverse Event Reporting System (VAERS).Vaccine2006
16817805Correlates of public health workforce acceptance of smallpox immunization in Virginia.Public Health Nurs2006
15687455Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.Pediatrics2005
15629350Photophobia following smallpox vaccination.Vaccine2005
  • 1 - 35 of 35

Recommended Authors

Research Institute at Nationwide Children's Hospital
Career Start Year 2015
Number of shared co-authors 0
Center for Drug Evaluation and Research
Career Start Year 2010
Number of shared co-authors 4
Vanderbilt University Medical Center, Vanderbilt University
Career Start Year 2010
Number of shared co-authors 0
Harvard Pilgrim Health Care Institute and Harvard Medical School
Career Start Year 2009
Number of shared co-authors 3
The University of Utah
Career Start Year 2008
Number of shared co-authors 0
Veterans Affairs Geriatrics Research Education and Clinical Center
Career Start Year 2006
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Boston Children's Hospital
Career Start Year 2002
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 1
Baylor College of Medicine
Career Start Year 2000
Number of shared co-authors 1
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 4
Hospital Clinico Universitario de Santiago de Compostela
Career Start Year 1998
Number of shared co-authors 1
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 1
Center for Translational Research.
Career Start Year 1994
Number of shared co-authors 0
UCSF School of Medicine, University of California Health
Career Start Year 1993
Number of shared co-authors 1
Nationwide Children's Hospital
Career Start Year 1992
Number of shared co-authors 0
Division of Hospital Medicine.
Career Start Year 1992
Number of shared co-authors 1
Boston Children's Hospital, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 0
Hospital for Sick Children, University of Toronto
Career Start Year 1990
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 1
Emory University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Northwestern University, Feinberg Northwestern School of Medicine
Career Start Year 1988
Number of shared co-authors 0
University of Utah
Career Start Year 1987
Number of shared co-authors 1
Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University
Career Start Year 1987
Number of shared co-authors 1
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1986
Number of shared co-authors 2
George Washington University
Career Start Year 1985
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1982
Number of shared co-authors 3
University of Pittsburgh and University of Pittsburgh Medical Center
Career Start Year 1978
Number of shared co-authors 0
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 2

Collaborators

Center for Drug Evaluation and Research
Co-authored papers 8
Co-authored papers 5
BC Children's Hospital Research Institute
Co-authored papers 2
Institute of Translational Medicine, University of Liverpool
Co-authored papers 2
Center for Drug Evaluation and Research
Co-authored papers 2
National Institutes of Health
Co-authored papers 2
From the National Institutes of Health
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 1
Children's Mercy Hospital
Co-authored papers 1
Kaiser Permanente Washington Health Research Institute (C Hsu and RB Penfold)
Co-authored papers 1
Harvard University
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
the Lifestyle Related Disease Medical Center
Co-authored papers 1
Johns Hopkins University
Co-authored papers 1
Pediatrix Center for Research Education
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1
School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
Vanderbilt University School of Medicine
Co-authored papers 1
University Medical Center Utrecht
Co-authored papers 1
Center for Drug Evaluation and Research
Co-authored papers 1
Brigham & Women's Hospital
Co-authored papers 1
Stanford University
Co-authored papers 1
Duke University, Emory University, Society for Critical Care Medicine, University of Ontario Institute of Technology, University of Tennessee Health Science Center
Co-authored papers 1
Co-authored papers 1
University of Tennessee Health Science Center
Co-authored papers 1
Children's Mercy Hospitals and Clinics
Co-authored papers 1